Ψ-DODFMO

Ψ-DODFMO, also known as 4-difluoromethoxy-2,6-dimethoxyamphetamine, is a psychedelic drug of the phenethylamine, amphetamine, and ψ-phenethylamine families. It is the amphetamine analogue of ψ-2C-DFMO and is also structurally related to other psychedelics like difluoromescaline and 2C-T-35. The drug has been found to be active at a dose of 5mg plus 5mg orally, with moderately intense effects and a relatively long duration of around 20hours. Ψ-DODFMO was first described in the scientific literature by Daniel Trachsel in 2012. It is a controlled substance in Canada under phenethylamine blanket-ban language.